# India is set to get its first mRNA vaccine , albeit through a donation, from Moderna. And drugmaker Cipla will facilitate the through-pass. That said, it paves the way for more strategic partnerships to bring next-gen vaccines into the country.
# Staying with vaccines, Indian Immunologicals makes progress with its Covid-19 vaccine, as it seeks regulatory approvals for early phase human trials.
# The EU “green-pass” has been causing much heartburn for Indians vaccinated with Serum Institute’s Covishield. But here’s a clarification from official sources .
# And here’s what the European regulatory authority on medicines and vaccines has to say on it. Unnecessary anxiety, say industry-insiders, specially when Covishield is deployed in the UK and has a WHO listing for emergency use as well.
# Domestic pharma majors explore collaborative research on a Covid-19 drug. A first time for the sector, heralds interesting times ahead ....
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.